Treatment of bacterial diseases of the respiratory organs
View Patent ↗The invention relates to inhalable quinolonecarboxylic acid derivative compositions for local control of diseases of the respiratory organs, in particular of lung diseases.
1. A method of treating a bacterial disease of the lungs in a human or animal comprising the step of locally administering an antibacterially effective amount of a ciprofloxacin embonate or enrofloxacin embonate, in a powder form or powder-containing suspension.
2. A method of treating a bacterial disease of the lungs in a human or animal comprising the step of locally administering an antibacterially effective amount of a ciprofloxacin hemiembonate or enrofloxacin hemiembonate, in a powder form or powder-containing suspension.
3. A method of treating a bacterial disease of the lungs in a human or animal comprising the step of locally administering an antibacterially effective amount of:
a mixture of ciprofloxacin embonate and ciprofloxacin hemiembonate, or
a mixture of enrofloxacin embonate and enrofloxacin hemiembonate,
in a powder form or powder-containing suspension.